LIF- and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation

Norihiko Ohbayashi1, Osamu Ikeda, Naohisa Taira

  • 1Department of Immunology, Graduate School of Pharmaceutical Sciences Hokkaido University, Kita-ku, Sapporo, Japan.

Insights

Leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) activate signal transducer and activator of transcription 3 (STAT3) through acetylation at Lys-685, mediated by the PI3K/Akt pathway.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Signal transducer and activator of transcription 3 (STAT3) regulates numerous physiological processes.
  • STAT3 activation involves phosphorylation, dimerization, and nuclear translocation.
  • Previous research identified Lys-685 acetylation by p300 as critical for STAT3 activation.

Purpose of the Study:

  • To investigate the role of STAT3 acetylation at Lys-685 in response to specific cytokines.
  • To elucidate the signaling pathway involved in STAT3 Lys-685 acetylation.

Main Methods:

  • Development of an antibody specific to acetylated STAT3 at Lys-685.
  • Treatment of 293T and Hep3B cells with leukemia inhibitory factor (LIF) or interleukin-6 (IL-6).
  • Inhibition of the PI3K/Akt pathway using LY294002 or a dominant-negative Akt mutant.

Main Results:

  • LIF and IL-6 induced STAT3 acetylation at Lys-685 in treated cells.
  • STAT3 Lys-685 acetylation was significantly reduced by PI3K/Akt pathway inhibitors.
  • Endogenous STAT3 acetylation at Lys-685 is confirmed to be regulated by LIF/IL-6 via PI3K/Akt.

Conclusions:

  • STAT3 acetylation at Lys-685 is a key regulatory event induced by LIF and IL-6.
  • The PI3K/Akt signaling pathway is essential for mediating STAT3 Lys-685 acetylation.
  • This study provides novel insights into the post-translational modification and activation of STAT3.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...